216 related articles for article (PubMed ID: 1594243)
1. Transformation by Jun: requirement for leucine zipper, basic region and transactivation domain and enhancement by Fos.
Morgan IM; Ransone LJ; Bos TJ; Verma IM; Vogt PK
Oncogene; 1992 Jun; 7(6):1119-25. PubMed ID: 1594243
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of jun transformation by a mutated fos gene: design of an anti-oncogene.
Okuno H; Suzuki T; Yoshida T; Hashimoto Y; Curran T; Iba H
Oncogene; 1991 Sep; 6(9):1491-7. PubMed ID: 1923517
[TBL] [Abstract][Full Text] [Related]
3. fos-jun Conspiracy: implications for the cell.
Verma IM; Ransone LJ; Visvader J; Sassone-Corsi P; Lamph WW
Princess Takamatsu Symp; 1989; 20():119-26. PubMed ID: 2518685
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of action of a dominant-negative mutant of c-Jun.
Brown PH; Chen TK; Birrer MJ
Oncogene; 1994 Mar; 9(3):791-9. PubMed ID: 8108121
[TBL] [Abstract][Full Text] [Related]
5. Analysis of dimerization and DNA binding functions in Fos and Jun by domain-swapping: involvement of residues outside the leucine zipper/basic region.
Cohen DR; Curran T
Oncogene; 1990 Jun; 5(6):929-39. PubMed ID: 2113670
[TBL] [Abstract][Full Text] [Related]
6. Structure and transcriptional regulation of BKJ, a novel AP-1 target gene activated during jun- or fos-induced fibroblast transformation.
Hartl M; Bister K
Oncogene; 1998 Dec; 17(22):2901-13. PubMed ID: 9879996
[TBL] [Abstract][Full Text] [Related]
7. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
Echlin DR; Tae HJ; Mitin N; Taparowsky EJ
Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209
[TBL] [Abstract][Full Text] [Related]
8. Suppression of oncogene-induced transformation by a deletion mutant of c-jun.
Brown PH; Alani R; Preis LH; Szabo E; Birrer MJ
Oncogene; 1993 Apr; 8(4):877-86. PubMed ID: 8455942
[TBL] [Abstract][Full Text] [Related]
9. Mutagenesis of the DNA contact site in Fos protein: compatibility with the scissors grip model and requirement for transformation.
Neuberg M; Schuermann M; Müller R
Oncogene; 1991 Aug; 6(8):1325-33. PubMed ID: 1909428
[TBL] [Abstract][Full Text] [Related]
10. Encounters with Fos and Jun on the road to AP-1.
Abate C; Curran T
Semin Cancer Biol; 1990 Feb; 1(1):19-26. PubMed ID: 2133107
[TBL] [Abstract][Full Text] [Related]
11. Jun and Fos heterodimerize with ATFa, a member of the ATF/CREB family and modulate its transcriptional activity.
Chatton B; Bocco JL; Goetz J; Gaire M; Lutz Y; Kedinger C
Oncogene; 1994 Feb; 9(2):375-85. PubMed ID: 8290251
[TBL] [Abstract][Full Text] [Related]
12. The Myb leucine zipper is essential for leukemogenicity of the v-Myb protein.
Bartůnek P; Karafiát V; Dvoráková M; Záhorová V; Mandíková S; Zenke M; Dvorák M
Oncogene; 1997 Dec; 15(24):2939-49. PubMed ID: 9416837
[TBL] [Abstract][Full Text] [Related]
13. Heterodimerization with c-Fos is not required for cell transformation of chicken embryo fibroblasts by Jun.
Hughes M; Sehgal A; Hadman M; Bos T
Cell Growth Differ; 1992 Dec; 3(12):889-97. PubMed ID: 1472469
[TBL] [Abstract][Full Text] [Related]
14. Directed mutation of the basic domain of v-Jun alters DNA binding specificity and abolishes its oncogenic activity in chicken embryo fibroblasts.
Basso J; Briggs J; Findlay C; Bos T
Oncogene; 2000 Oct; 19(42):4876-85. PubMed ID: 11039905
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Fos- and Ras-induced transformation by mutant Fos proteins with structural alterations in functionally different domains.
Wick M; Lucibello FC; Müller R
Oncogene; 1992 May; 7(5):859-67. PubMed ID: 1570155
[TBL] [Abstract][Full Text] [Related]
16. Maf and Nrl can bind to AP-1 sites and form heterodimers with Fos and Jun.
Kerppola TK; Curran T
Oncogene; 1994 Mar; 9(3):675-84. PubMed ID: 8108109
[TBL] [Abstract][Full Text] [Related]
17. Jun DNA-binding is modulated by mutations between the leucines or by direct interaction of fos with the TGACTCA sequence.
Hirai S; Yaniv M
New Biol; 1989 Nov; 1(2):181-91. PubMed ID: 2562220
[TBL] [Abstract][Full Text] [Related]
18. Amino acid substitutions modulate the effect of Jun on transformation, transcriptional activation and DNA replication.
Morgan IM; Asano M; Håvarstein LS; Ishikawa H; Hiiragi T; Ito Y; Vogt PK
Oncogene; 1993 May; 8(5):1135-40. PubMed ID: 8479738
[TBL] [Abstract][Full Text] [Related]
19. Transactivation activity of Maf nuclear oncoprotein is modulated by Jun, Fos and small Maf proteins.
Kataoka K; Noda M; Nishizawa M
Oncogene; 1996 Jan; 12(1):53-62. PubMed ID: 8552399
[TBL] [Abstract][Full Text] [Related]
20. Functional dissection of AP-1 transcription factors using the Gal4 adaptor assay.
Smith SE; Bohmann D
Cell Growth Differ; 1992 Aug; 3(8):523-9. PubMed ID: 1390338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
